Skip to Content
MilliporeSigma
All Photos(1)

Documents

Y0001256

Levetiracetam impurity C

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

2-Hydroxypyridine, 2(1H)-Pyridone, 2-Pyridinol

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C5H5NO
CAS Number:
142-08-5
Molecular Weight:
95.10
Beilstein/REAXYS Number:
105757
MDL number:
MFCD00006268
UNSPSC Code:
41116107
PubChem Substance ID:
329831326
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

levetiracetam

manufacturer/tradename

EDQM

bp

280-281 °C (lit.)

mp

105-107 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

Oc1ccccn1

InChI

1S/C5H5NO/c7-5-3-1-2-4-6-5/h1-4H,(H,6,7)

InChI key

UBQKCCHYAOITMY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Levetiracetam impurity C EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

1359404

Levetiracetam, United States Pharmacopeia (USP) Reference Standard

1359437

Levetiracetam Related Compound B, United States Pharmacopeia (USP) Reference Standard

1359415

Levetiracetam Racemic Mixture, United States Pharmacopeia (USP) Reference Standard

1359426

Levetiracetam Related Compound A, United States Pharmacopeia (USP) Reference Standard

Y0001253

Levetiracetam, European Pharmacopoeia (EP) Reference Standard

Y0001254

Levetiracetam impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001257

Levetiracetam impurity D, European Pharmacopoeia (EP) Reference Standard

Y0000659

Pyrrolidone, European Pharmacopoeia (EP) Reference Standard

PHR1447

Levetiracetam, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001962

Levetiracetam impurity E, European Pharmacopoeia (EP) Reference Standard

Y0001948

Levetiracetam impurity G, European Pharmacopoeia (EP) Reference Standard

PHR2432

Levetiracetam Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2428

Levetiracetam Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2417

Levetiracetam Racemic Mixture, Pharmaceutical Secondary Standard; Certified Reference Material

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301

Hazard Classifications

Acute Tox. 3 Oral

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

Levetiracetam United States Pharmacopeia (USP) Reference Standard

USP

1359404

Levetiracetam

Levetiracetam ≥98% (HPLC)

Sigma-Aldrich

L8668

Levetiracetam

Istvan Horvath et al.
Archives of biochemistry and biophysics, 532(2), 84-90 (2013-02-13)
In a recent study we discovered that a ring-fused 2-pyridone compound triggered fibrillization of a key protein in Parkinson's disease, α-synuclein. To reveal how variations in compound structure affect protein aggregation, we now prepared a number of strategic analogs and
Mingwen Zhu et al.
Chemical communications (Cambridge, England), 47(48), 12876-12878 (2011-11-15)
A highly efficient and convenient CuCl/2-pyridonate catalytic system for oxidative homocoupling of azoles affording a biazole product has been developed. With this system, a variety of biazoles have been effectively synthesized in good to excellent yields in the presence of
Amanda L Steber et al.
Faraday discussions, 150, 227-242 (2011-01-01)
Studies of the gas phase structures of biomolecules provide an important connection to theoretical methods for modeling large molecular structures. The key features of biomolecule structures, such as their conformational flexibility and the complexes they form through intermolecular interactions, pose
Christian Wiegand et al.
Chemical communications (Cambridge, England), 48(82), 10195-10197 (2012-09-11)
3-Substituted 2-pyridones were enantioselectively (68-90% ee) converted into the respective 3-hydroxypyridine-2,6-diones by a sequence consisting of a template-mediated type II photooxygenation and an acid-catalysed rearrangement.
Elango Kumarasamy et al.
Journal of the American Chemical Society, 133(43), 17106-17109 (2011-10-11)
Nonbiaryl axially chiral 2-pyridones were synthesized and employed for light-induced electrocyclic 4π ring closure leading to bicyclo-β-lactam photoproducts in solution. The enantioselectivity in the photoproducts varied from 22 to 95% depending on the reaction temperature and the ability of the
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service